1T-AL-LAD
| Clinical data | |
|---|---|
| Other names | 1-(Thiophene-2-carbonyl)-AL-LAD |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C27H29N3O2S |
| Molar mass | 459.61 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1T-AL-LAD, also known as 1-(thiophene-2-carbonyl)-AL-LAD, is a psychedelic lysergamide derivative which has been sold as a designer drug, first reported in April 2024. It is believed to act as a prodrug for AL-LAD in a similar manner to how 1P-LSD acts as a prodrug for LSD.